Uroplakin Ib gene transcription in urothelial tumor cells is regulated by CpG methylation

Neoplasia

Volumn 7, Issue 12, 2005, Pages 1091-1103

  Cowled, Prue ^a   Kanter, Irene ^a   Leonardos, Lefta ^a   Jackson, Paul ^b,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Methylation; NF B; Sp1; Transcriptional regulation; Uroplakin ib

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; UROPLAKIN; UROPLAKIN 1 B; CHLORAMPHENICOL ACETYLTRANSFERASE; LUCIFERASE; MEMBRANE PROTEIN; UPK1B PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CPG ISLAND; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; PROTEIN MOTIF; PROTEIN PURIFICATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TRANSCRIPTION TERMINATION; UROGENITAL TRACT TUMOR; BLADDER TUMOR; CELL CULTURE; COMPARATIVE STUDY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; UROTHELIUM;

BASE SEQUENCE; CELLS, CULTURED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CPG ISLANDS; DNA METHYLATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR; TRANSFECTION; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 33644877079     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.05364     Document Type: Article

References (27)

1. Yu J, Lin JH, Wu XR, and Sun TT (1994). Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J Cell Biol 125, 171-182.
2. Boucheix C and Rubinstein E (2001). Tetraspanins. Cell Mol Life Sci 58, 1189-1205.
3. Hemler MM (2001). Specific tetraspanin functions. J Cell Biol 155, 1103-1108.
4. Yu J, Manabe M, Wu XR, Xu C, Surya B, and Sun TT (1990). Uroplakin I: a 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium. J Cell Biol 111, 1207-1216.
5. Wu XR, Lin JH, Walz T, Haner M, Yu J, Aebi U, and Sun TT (1994). Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem 269, 13716-13724.
6. Deng FM, Liang FX, Tu L, Resing KA, Hu P, Supino M, Hu CC, Zhou G, Ding M, Kreibich G, and Sun TT (2002). Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin 1b as an early step of urothelial plaque assembly. J Cell Biol 159, 685-694.
7. Tu L, Sun TT, and Kreibich G (2002). Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum. Mol Biol Cell 13, 4221-4230.
8. Adachi W, Okubo K, and Kinoshita S (2000). Human uroplakin 1b in ocular surface epithelium. Invest Ophthalmol Vis Sci 41, 2900-2905.
9. Olsburgh J, Harnden P, Weeks R, Smith B, Joyce A, Hall G, Poulsom R, Selby P, and Southgate J (2003). Uroplakin gene expression in normal human tissues and locally advanced bladder cancer. J Pathol 199, 41-49.
10. Tarrant JM, Robb L, van Spriel AB, and Wright MD (2003). Tetraspanins: molecular organisers of the leukocyte surface. Trends Immunol 24, 610-617.
11. Yunta M and Lazo PA (2003). Tetraspanin proteins as organisers of membrane microdomains and signalling complexes. Cell Signal 15, 559-564.
12. Ow K, Delprado W, Fisher R, Barrett J, Yu Y, Jackson P, and Russell PJ (2000). Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer. J Pathol 191, 39-47.
13. Huang CI, Kohno N, Ogawa E, Adachi M, Taki T, and Miyake M (1998). Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol 153, 973-983.
14. Su JS, Arima K, Hasegawa M, Franco OE, Umeda Y, Yanagawa M, Sugimura Y, and Kawamura J (2004). Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma. Int J Urol 11, 74-82.
15. Takaoka A, Hinoda Y, Satoh S, Adachi Y, Itoh F, Adachi M, and Imai K (1998). Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 16, 1443-1453.
16. Yang X, Wei LL, Tang C, Slack R, Mueller S, and Lippman ME (2001). Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 61, 5284-5288.
17. Jee B, Jin K, Hahn JH, Song HG, and Lee H (2003). Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway. Exp Mol Med 35, 30-37.
18. Ikeyama S, Koyama M, Yamaoko M, Sasada R, and Miyake M (1993). Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 177, 1231-1237.
19. Radford KJ, Mallesch J, and Hersey P (1995). Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer 62, 631-635.
20. Moseley GW, Elliott J, Wright MD, Partridge LJ, and Monk PN (2003). Interspecies contamination of the KM3 cell line: implications for CD63 function in melanoma metastasis. Int J Cancer 105, 613-616.
21. Varga AE, Leonardos L, Jackson P, Marreiros A, and Cowled PA (2004). Methylation of a CpG island within the uroplakin 1b promoter: a possible mechanism for loss of uroplakin 1b expression in bladder carcinoma. Neoplasia 6, 128-135.
22. Olsburgh J, Weeks R, Selby P, and Southgate J (2002). Human uroplakin Ib gene structure and promoter analysis. Biochim Biophys Acta 1576, 163-170.
23. Singal R, Ferris R, Little JA, Wang SZ, and Ginder GD (1997). Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells. Proc Natl Acad Sci USA 94, 13724-13729.
24. Esteller M (2005). Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 45, 629-656.
25. Perkins ND, Agranoff AB, Pascal E, and Nabel GJ (1994). An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol Cell Biol 14, 6570-6583.
26. Zhang J, Ramesh N, Chen Y, Li Y, Dilley J, Working P, and Yu DC (2002). Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel. Cancer Res 62, 3743-3750.
27. Kinoshita S, Adachi W, Sotozono C, Nishida K, Yokoi N, Quantock AJ, and Okubo K (2001). Characteristics of the human ocular surface epithelium. Prog Retin Eye Res 20, 639-673.